4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001415889-24-004471
Director sold 510,152 shares at an average $23.26 ($11,867,292)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rhodes Jason P Director | 2024-02-15 | Sale 10b5-1 | −175,793 | $23.88 | $4,197,937 | 7,150,324 | I |
| Rhodes Jason P Director | 2024-02-15 | Sale 10b5-1 | −2,113 | $24.45 | $51,663 | 7,148,211 | I |
| Rhodes Jason P Director | 2024-02-16 | Sale 10b5-1 | −162,707 | $23.14 | $3,765,040 | 6,985,504 | I |
| Rhodes Jason P Director | 2024-02-20 | Sale 10b5-1 | −166,029 | $22.71 | $3,770,519 | 6,819,475 | I |
| Rhodes Jason P Director | 2024-02-20 | Sale 10b5-1 | −3,510 | $23.40 | $82,134 | 6,815,965 | I |
| Open-market sales · 510,152 sh · avg $23.26 · $11,867,292 | |||||||
Loading xslF345X05/form4-02202024_110236.xml…